TWO · Financial Statements

SunWay Biotech Co., LTD. (1271.TWO) Financial Statements

$58.70 TWO: 1271.TWO Market Cap $3.58B

Full income statement, balance sheet, and cash flow statement for SunWay Biotech Co., LTD. (1271.TWO), plus valuation and return ratios.

Annual financials are not yet available for this stock.

Valuation & Return Ratios

MetricValue
PEG Ratio0.38
EV / EBITDA30.06
FCF Yield—
Quick Ratio0.92
Interest Coverage—
Return 1Y-10.32%
Return 3Y-26.74%
Return 5Y17.96%

SunWay Biotech Co., LTD. (1271.TWO) financials — frequently asked questions

What is 1271.TWO EV/EBITDA?

SunWay Biotech Co., LTD.'s enterprise value to EBITDA (EV/EBITDA) ratio is 30.06.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
1271.TWO Overview 1271.TWO Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.